A groundbreaking discovery has emerged from Singapore, offering a glimmer of hope for diabetic patients struggling with excess belly fat. The power of magnetic pulses has been unveiled as a potential game-changer in diabetes management.
A collaborative study between Singapore General Hospital (SGH) and the National University of Singapore (NUS) has revealed that non-invasive magnetic pulses can effectively lower long-term blood sugar levels in diabetic patients with central obesity. This innovative approach provides an exciting avenue for adjuvant therapy, complementing traditional diabetes treatments.
Over a period of 12 weeks, 40 adult patients with poorly controlled Type 2 diabetes underwent weekly sessions of 10-minute magnetic pulses delivered to one leg, alternating legs each week. The low-dose pulsed electromagnetic fields mimic the effects of exercise by stimulating mitochondria, the body's energy producers.
The results were remarkable. A blood test conducted before and after the treatment revealed that patients with excess belly fat experienced a significant reduction in blood sugar levels, bringing them closer to the target range for well-controlled diabetes. Specifically, the haemoglobin A1c (HbA1c) blood test, which measures average glucose levels over two to three months, showed a drop in HbA1c levels from 7.5% to 7.1% among patients with central obesity.
But here's where it gets controversial: only one-third of patients without central obesity saw a reduction in HbA1c levels. This disparity highlights the potential of magnetic pulses as a targeted treatment for those with excess belly fat.
Dr Tan Hong Chang, a senior consultant at SGH's endocrinology department, emphasized the significance of these findings: "With improved HbA1c levels, patients can reduce their risk of long-term complications affecting the kidneys, eyes, heart, and nerves."
The timing of this study is particularly relevant, as obesity rates in Singapore have risen to 12.7%, up from 10.5% between 2019 and 2024. Health Minister Ong Ye Kung has expressed concern, highlighting the urgent need to address obesity and poor mental health collectively.
While doctors typically advise diabetic patients to exercise alongside medication and healthy diets, the reality is that many patients face barriers to physical activity. This is where the Bixeps machine, developed by NUS Research Associate Professor Alfredo Franco-Obregon, steps in as a viable alternative.
"For those unable to exercise due to various reasons, the Bixeps machine offers a promising option," Prof Franco-Obregon said. The machine, developed when he was at ETH Zurich, is now being commercialized through QuantumTX, a company he co-owns.
The SGH and NUS researchers are now planning longer-term studies to further explore the potential of magnetic pulse therapy. The next trial will focus on patients with diabetes, central obesity, and sarcopenia, a condition affecting older adults who lose muscle mass and function. The trial, lasting up to a year, aims to determine the optimal treatment duration and frequency and identify the patient groups most likely to benefit.
This innovative approach to diabetes management raises intriguing questions: Could magnetic pulses revolutionize the way we treat diabetes? What are the long-term implications and potential side effects? Share your thoughts and opinions in the comments below!
